Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Observation group:Basic treatment, including general treatment such as rest, strengthened support treatment, close monitoring of vital signs, oxygen therapy, antibacterial drug treatment, anti COVID-1
control group:Basic treatment, including general treatment such as rest, strengthened support treatment, close monitoring of vital signs, oxygen therapy, antibacterial drug treatment, anti COVID-19 dr
Sponsors
Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University
Eligibility
Sex/Gender
All
Age
45 Years to 90 Years
Inclusion criteria
Inclusion criteria: (1) Conform to diagnostic criteria of coronavirus disease 2019; (2) The age is more than 45 years old and less than 90 years old; (3) Within one month, the patient was newly infected with COVID-19 and had related clinical symptoms; (4) The vital signs of patients were stable; (5) Sign the informed consent form voluntarily and receive Fus subcutaneous needling.
Exclusion criteria
Exclusion criteria: (1) Body temperature = 37.3 ?; (2) Those who have poor mental status, can not cooperate, or suffer from mental diseases, have no self-control, and can not express clearly, can not accept floating needle treatment, or can not cooperate to complete the efficacy evaluation due to other reasons; (3) Subjects participate in other clinical studies after infection; (4) Accompanied with serious cardiovascular and cerebrovascular diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the cough VAS;Evaluation Scale of Therapeutic Effect of Traditional Chinese Medicine on coronavirus disease 2019 (COVID-19); | — |
Secondary
| Measure | Time frame |
|---|---|
| MMrc score;Fatigue Scale-14,FS-14;Inflammatory indicators;CT imaging changes;Hospitalization days;7-day discharge rate; | — |
Countries
china
Contacts
Public ContactBai Tianyu
Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University
Outcome results
None listed